SHINE Medical Technologies received a $15 million award from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the company announced today.

“We are grateful for DOE/NNSA’s award as SHINE continues its progress toward production of Mo-99 and other important medical isotopes,” SHINE CEO Greg Piefer said in a statement. “The recent DOE/NNSA award directly supports SHINE’s continued advancement as we work to supply lifesaving medical tracers and therapeutics to an underserved, growing global market.”

According to a release, the award by the DOE/NNSA was part of its effort to establish a reliable, U.S.-produced supply of molybdenum-99 (Mo-99).

Last month, SHINE filed an application with the U.S. Nuclear Regulatory Commission to produce medical isotopes.